Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leiv Ose

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Atherosclerosis|November 3, 2010
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10Ingunn Narverud, Thor Ueland, Marit S Nenseter, et al.
American Heart Journal|December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAnders G Olsson, Helge Istad, Olavi Luurila, et al.
Frontiers in Pharmacology|March 19, 2021
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective StudyKjell-Erik Arnesen, Ann Vinh Phung, Karoline Randsborg, et al.
Clinical Therapeutics|January 11, 2005
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemiaHarold E Bays, Leiv Ose, Neil Fraser, et al.
European Journal of Preventive Cardiology|August 26, 2016
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry studyLiv Mundal, Marit B Veierød, Thomas Halvorsen, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndromeTheodore Feldman, Leiv Ose, Arvind Shah, et al.
Atherosclerosis|February 18, 2014
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatmentKirsten B Holven, Ingunn Narverud, Henriette W Lindvig, et al.
Atherosclerosis|June 9, 2014
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature reviewIngunn Narverud, Kjetil Retterstøl, Per Ole Iversen, et al.
Journal of Clinical Lipidology|July 28, 2012
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemiaAsgeir Græsdal, Martin Prøven Bogsrud, Kirsten Bjørklund Holven, et al.
Atherosclerosis|August 6, 2016
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemiaKristin Torvik, Ingunn Narverud, Inger Ottestad, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Atherosclerosis|November 3, 2010
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10Ingunn Narverud, Thor Ueland, Marit S Nenseter, et al.
American Heart Journal|December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAnders G Olsson, Helge Istad, Olavi Luurila, et al.
Frontiers in Pharmacology|March 19, 2021
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective StudyKjell-Erik Arnesen, Ann Vinh Phung, Karoline Randsborg, et al.
Clinical Therapeutics|January 11, 2005
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemiaHarold E Bays, Leiv Ose, Neil Fraser, et al.
European Journal of Preventive Cardiology|August 26, 2016
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry studyLiv Mundal, Marit B Veierød, Thomas Halvorsen, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndromeTheodore Feldman, Leiv Ose, Arvind Shah, et al.
Atherosclerosis|February 18, 2014
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatmentKirsten B Holven, Ingunn Narverud, Henriette W Lindvig, et al.
Atherosclerosis|June 9, 2014
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature reviewIngunn Narverud, Kjetil Retterstøl, Per Ole Iversen, et al.
Journal of Clinical Lipidology|July 28, 2012
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemiaAsgeir Græsdal, Martin Prøven Bogsrud, Kirsten Bjørklund Holven, et al.
Atherosclerosis|August 6, 2016
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemiaKristin Torvik, Ingunn Narverud, Inger Ottestad, et al.
Pageof 8